CP
CLBT icon

CenterBook Partners’s Cellebrite CLBT Stock Holding History

CenterBook Partners’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.46M Buy
+178,506
New +$2.69M 0.13% 196
2025
Q1 		– Sell
-13,720
Closed -$302K – 490
2024
Q4 		$302K Sell
13,720
-14
-0.1% -$269 0.02% 451
2024
Q3 		$231K Sell
13,734
-283,935
-95% -$4.21M 0.01% 433
2024
Q2 		$3.56M Sell
297,669
-445,172
-60% -$4.97M 0.22% 180
2024
Q1 		$8.23M Buy
+742,841
New +$7.58M 0.57% 35

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CenterBook Partners's CLBT Position: Q1 2026 in Review

CenterBook Partners opened a new position in Cellebrite (CLBT) in Q1 2026: 178,506 shares worth $2.46M. The stake represents 0.13% of the portfolio and ranks #196 among its holdings. This is a return to the name: CenterBook Partners previously reported a position in CLBT as recently as Q4 2024.

CenterBook Partners first reported a position in CLBT in Q1 2024 and has held it in 5 quarters since. The position peaked at $8.23M in Q1 2024. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • CenterBook Partners held 178,506 shares of Cellebrite worth $2.46M as of Q1 2026.
  • Cellebrite was a new CenterBook Partners position in Q1 2026.
  • Cellebrite made up 0.13% of CenterBook Partners's portfolio in Q1 2026, its #196 holding.
  • CenterBook Partners first reported a position in Cellebrite in Q1 2024 and has held it in 5 quarters since.
  • CenterBook Partners's Cellebrite position peaked at $8.23M in Q1 2024.
  • 220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on CenterBook Partners's 13F filing for Q1 2026, filed 5 May 2026.